Page last updated: 2024-08-17

adenosine monophosphate and Viremia

adenosine monophosphate has been researched along with Viremia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bannister, R; Bavari, S; Cihlar, T; Donnelly, G; Garza, NL; Gomba, L; Iversen, PL; Kane, CD; Norris, S; Porter, DP; Steffens, J; Stuthman, KS; Van Tongeren, SA; Warren, TK; Weidner, JM; Wells, J; Zeng, X1
Bunyan, E; Jordan, R; Julander, JG; Porter, DP1
Bannister, R; Cihlar, T; Cronin, J; de Wit, E; Feldmann, F; Feldmann, H; Gary, JM; Jordan, R; Klena, JD; Lo, MK; Nichol, ST; Patel, NR; Spiropoulou, CF; Zaki, SR1

Other Studies

3 other study(ies) available for adenosine monophosphate and Viremia

ArticleYear
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus.
    Scientific reports, 2021, 09-30, Volume: 11, Issue:1

    Topics: Adenosine Monophosphate; Administration, Intravenous; Aerosols; Alanine; Animals; Antiviral Agents; Disease Models, Animal; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Kaplan-Meier Estimate; Liver; Lung; Lymph Nodes; Macaca mulatta; Male; Random Allocation; Systemic Inflammatory Response Syndrome; Viral Load; Viremia

2021
Remdesivir efficacy against yellow fever in a hamster model.
    Antiviral research, 2022, Volume: 203

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cricetinae; Viremia; Yellow Fever; Yellow Fever Vaccine; Yellow fever virus

2022
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.
    Science translational medicine, 2019, 05-29, Volume: 11, Issue:494

    Topics: Adenosine Monophosphate; Alanine; Animals; Brain; Chlorocebus aethiops; Female; Henipavirus Infections; Male; Meningoencephalitis; Neutralization Tests; Nipah Virus; Viremia; Virus Replication

2019